// App-Quantinova.ai

2834 : Correlation Of Longitudinal Blood Counts With Thromboembolic Complications In WHO 2008 Defined Prefibrotic Primary Myelofibrosis

Researchers

Presenter

  • Veronika Buxhofer-Ausch

Principal Investigators

  • Martin Schalling

  • Sophie Frantal

  • Jurgen Thiele

  • Leonhard Muellauer

  • Hans-Michael Kvasnicka

  • Bettina Gisslinger

  • Heinz Gisslinger

Medical Centers

  • Department of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria

  • Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria

  • Institute of Pathology University of Frankfurt/M, Frankfurt/M, Germany.

  • Institute of Neurology, Medical University of Vienna, Vienna, Austria

  • Dept. of Medicine I, Div. of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria

  • Center for Medical Statistics, Medical University of Vienna, Vienna, Austria

  • Institute of Pathology, University Hospital of Cologne, Cologne, Germany

Locations

  • Germany

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myeloid neoplasms

  • Essential thrombocythemia

  • Venous thrombosis

  • Myelofibrosis

Biomarkers

  • White Blood Cell

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim